Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Mandarin Oriental Washington D.C.

Jan 23, 2017 7:30 AM - Jan 25, 2017 3:15 PM

1330 Maryland Avenue, SW, Washington, DC 20024

Pharmacovigilance and Risk Management Strategies Conference

Round Table Luncheon Discussions

Session Chair(s)

Round Table  Discussions

Round Table Discussions

, United States

There will be a 30 minute session for a limited number of participants to join roundtable discussions during the lunch break. Key thought leaders will help facilitate the discussions.

Speaker(s)

Sanjay K Sahoo

Sanjay K Sahoo

Associate Director, Tools, Technology, and Innovation, OCS, OTS, CDER, FDA, United States

Suranjan  De, MBA, MS

Suranjan De, MBA, MS

Deputy Director, Regulatory Science, OSE, CDER, FDA, United States

Sonja  Brajovic, MD

Sonja Brajovic, MD

Medical Officer, OSE, CDER , FDA, United States

Judy  Harrison, MD

Judy Harrison, MD

Chief Medical Officer, United States

E. Stewart  Geary, MD

E. Stewart Geary, MD

MD, Global Safety Officer, Eisai Co., Ltd., Japan

Stephen  Knowles, MD, MRCP

Stephen Knowles, MD, MRCP

Chief Medical Officer, Halozyme Therapeutics, United States

Annette S. Williams, MBA, RPH

Annette S. Williams, MBA, RPH

Vice President, Pharmacovigilance, IQVIA, United States

Mick  Foy

Mick Foy

Director of Delivery, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Thomas  Felix, MD

Thomas Felix, MD

Medical Director, R&D Policy, Global Regulatory Affairs and Safety, Amgen Inc., United States

Jill W. Buckley, PHARMD

Jill W. Buckley, PHARMD

Adjunct Assistant Professor, Rutgers, the State University of New Jersey, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.